Robert W. Duggan - 15 Aug 2025 Form 4 Insider Report for PULSE BIOSCIENCES, INC. (PLSE)

Role
Director, 10%+ Owner
Signature
/s/ Kenneth B. Stratton, as Attorney-in-Fact
Issuer symbol
PLSE
Transactions as of
15 Aug 2025
Net transactions value
$0
Form type
4
Filing time
19 Aug 2025, 21:17:31 UTC
Previous filing
02 Jun 2025
Next filing
11 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
DUGGAN ROBERT W Director, 10%+ Owner 601 BRICKELL KEY DRIVE, SUITE 1080, MIAMI /s/ Kenneth B. Stratton, as Attorney-in-Fact 19 Aug 2025 0001055919

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PLSE Stock Option (right to buy) Award $0 +30,000 $0.000000 30,000 15 Aug 2025 Common Stock 30,000 $16.16 Direct F1
transaction PLSE Stock Option (right to buy) Award $0 +20,792 $0.000000 20,792 15 Aug 2025 Common Stock 20,792 $16.16 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option will vest in equal monthly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on September 15, 2025.
F2 The shares subject to the option will vest in equal quarterly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on September 5, 2025.